HENLIUS (02696) has been included in the list of stocks eligible for the Hong Kong Stock Connect.
Fuhong Hanlin (02696) announced that, based on the notices issued by the Shanghai Stock Exchange and the Shenzhen Stock Exchange regarding the adjustment of underlying stocks for the Hong Kong Stock Connect under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect respectively, the company has been included in the list of underlying stocks eligible for the Hong Kong Stock Connect. This adjustment will take effect from September 7, 2026.
HENLIUS (02696) announced that, according to the notices issued by the Shanghai Stock Exchange and the Shenzhen Stock Exchange regarding the adjustment of the eligible stocks under the Stock Connect program, the company has been included in the list of eligible stocks under the Stock Connect program starting from September 7, 2026.
The Stock Connect programs are channels for stock trading and investment between investors in Hong Kong and mainland China. Being included in the list of eligible stocks under the Stock Connect programs will help expand the company's shareholder base and enhance the liquidity of the companys shares, thereby further increasing the company's investment value in the capital market.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH) subsidiary SHR-1179 injection has been approved to conduct clinical trials.
SUNAC SERVICES (01516) repurchased 200,000 shares for HKD 164,500 on September 7.
SINOPEC CORP (00386) spent HKD 10.607 million on September 7 to repurchase 2.244 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH) subsidiary SHR-1179 injection has been approved to conduct clinical trials.
SUNAC SERVICES (01516) repurchased 200,000 shares for HKD 164,500 on September 7.
SINOPEC CORP (00386) spent HKD 10.607 million on September 7 to repurchase 2.244 million shares.
RECOMMEND
